Kiadis appoints Vincent Brichard to board
This article was originally published in Scrip
Executive Summary
Kiadis, a clinical-stage biopharmaceutical company developing immunotherapy treatments, has appointed Dr Vincent Brichard an independent member of its supervisory board. Dr Brichard, a physician by training, has more than 25 years' experience in the oncology and immunology field, including almost 15 years at GlaxoSmithKline where he was senior vice-president and had responsibility for the Immunotherapeutics Business Unit. In addition to this position, he served as a member of the board of directors at GSK Biologicals.